Cite
HARVARD Citation
Taïeb, J. et al. (2021). Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial. Digestive and liver disease. 53 (3), pp. 318-323. [Online].